Johnson & Johnson (NYSE:JNJ)
A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Here's the video pitch:
http://www.fool.com/investing/general/2012/02/13/the-5-year-outlook-for-this-dow-stock-johnson-.aspx
Recs
Such a diverse range of vital consumer goods, with numerous household names. What a great company to own!
Recs
Recs
Safe haven play.
Recs
Everyone knows about the dividend, the moat, the stability, the margin.
For some reason nobody is talking about Rivaroxaban. Its a huge drug. It'll help them with their growth and margins.
Recs
This company has product recalls every month. Their market share is going south. Well run companies do not have recall problems. This is not a well run company and the market will price that in the share price over the next 24 to 48 months.
Recs
3 companies that give back to shareholders,
http://www.fool.com/investing/general/2011/12/29/3-companies-that-give-back-to-shareholders.aspx?source=isesitlnk0000001&mrr=1.00
Recs
They make half of the stuff you have in your household. They have solid management. Brand loyalty. Trusted name. Win.
Recs
They make a variety of products that people can't live without. They aren't recession proof, but they are strongly recession resistant. They pay a solid dividend and have slow but continuous growth
Recs
Looking into 2012, JNJ is picking up a lot of endorsements from money and financial publications, making various "Top Ten Lists."
Recs
Pharma. Good Div. Nice value metrics. Long until death.
Recs
Great Franchise. Solid Dividends
Recs
Yield, balance sheet, ROI, cash flow.
Recs
Buffett has been selling, while he should be buying. I don't quite understand it, because he doesn't need the cash.
Recs
In a slower economy, JNJ has the lockdown on inelastic goods (medical devices), while in a more prosperous environment it has a leg up on competition in terms of R&D output and acquisition potential. Also has a solid dividend and decent PE at the moment.
Recs
Everyone knows Johnson & Johnson. They are the big dog in pharma, and the household name gives them a large moat in their consumer segment.
This company can withstand the test of time and market volatility. It has above average returns, and is priced cheaply. This is a great entry point into a great long term stock holding.
Recs
Back to basics again.
Recs
One of my faves.
Recs
Betting on JNJ value long term. Have read good things about this company that should see it grow well into the future.
Recs
This is a "Giant Tortoise Stock." Like a giant tortoise, It may be big and slow, but it has a hard shell (economic moat), can swim far (enter into new and emerging markets and industries), and live long.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 2167 : 1 2 3 4 5 6 7 8 9 10 Next »